-transparent.png){kind=logo}
SISO in doses of 1.0 to 1.8 mg/kg was administered by a 30-minute intravenous infusion every 12 hours to 10 patients with infections, 9 of whom had underlying diseases including malignant diseases, diabetes mellitus, and diabetes insipidus with indwelling FOLEY catheter. The serum concentration of SISO was around 6.75 micrograms/ml in the end of infusion, and less than 1.0 micrograms/ml at 8 to 12 hours after infusion. SISO was given to the patients as a single agent for at least 3 to 5 days and all patients experienced an excellent to good response clinically, and causative organisms which showed a minimal inhibitory concentration of less than 1.56 micrograms/ml disappeared after the treatment associated with clinical improvement. There were no untoward effects noted in this study.
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
September 1979,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
June 1985,
The Japanese journal of antibiotics,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
July 1984,
The Japanese journal of antibiotics,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
November 1985,
The Japanese journal of antibiotics,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
December 1996,
Seminars in oncology,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
January 1985,
Farmakologiia i toksikologiia,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
January 1976,
Scandinavian journal of infectious diseases. Supplementum,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
March 1987,
Clinical pharmacokinetics,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
July 1993,
The Japanese journal of antibiotics,
K Tamura, and
R Iwakiri, and
T Amamoto, and
M Seita
May 1965,
The Journal of laboratory and clinical medicine,
